CliffBio
small molecule

VITRAVENE PRESERVATIVE FREE

FOMIVIRSEN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameVITRAVENE PRESERVATIVE FREE
Active ingredientFOMIVIRSEN SODIUM
Strength6.6MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 1998
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.